nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

02.03.2019 | Letter to the Editor

In response to: The validity of ¹⁸F-GE180 as a TSPO imaging agent

verfasst von: Nathalie L. Albert, Marcus Unterrainer, Matthias Brendel, Lena Kaiser, Markus Zweckstetter, Paul Cumming, Peter Bartenstein

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Zanotti-Fregonara P, Veronese M, Pascual B, Rostomily RC, Turkheimer F, Masdeu JC. The validity of 18F-GE180 as a TSPO imaging agent. Eur J Nucl Med Mol Imaging. 2019. https://doi.org/10.1007/s00259-019-4268-4.CrossRefPubMed

Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, et al. TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis. Eur J Nucl Med Mol Imaging. 2018;45(8):1423–31.CrossRefPubMed

Vomacka L, Albert NL, Lindner S, Unterrainer M, Mahler C, Brendel M, et al. TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis. EJNMMI Res. 2017;7(1):89.CrossRefPubMedPubMedCentral

Albert NL, Unterrainer M, Fleischmann D, Lindner S, Vettermann F, Brunegraf A, et al. TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma. Eur J Nucl Med Mol Imaging. 2017;44(13):2230–8.CrossRefPubMed

Unterrainer M, Fleischmann D, Diekmann C, Vomacka L, Lindner S, Vettermann F, et al. Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study. Eur J Nucl Med Mol Imaging. 2019;46(3):580–90.CrossRefPubMed

Unterrainer M, Fleischmann DF, Lindner S, Brendel M, Rupprecht R, Tonn JC, et al. Detection of cerebrospinal fluid dissemination of recurrent glioblastoma using TSPO-PET with 18F-GE-180. Clin Nucl Med. 2018;43(7):518–9.CrossRefPubMed

Beyer L, Brendel M, Rohrer G, Sonnenfeld S, Nübling G, Lindner S, et al. Translocator protein 18kDa (TSPO) expression in patients with clinically diagnosed progressive Supranuclear palsy. J Nucl Med. 2018;59(Suppl 1):1700.

Schöberl F, Levin J, Remi J, Goldschagg N, Eren O, Okamura N, et al. IgLON5: a case with predominant cerebellar tau deposits and leptomeningeal inflammation. Neurology. 2018;91(4):180–2.CrossRefPubMed

Mahler C, Unterrainer M, Muth C, Egensperger R, Vomacka L, Lindner S, et al. Imaging microglial activation in tacrolimus-associated CNS vasculitis with translocator protein PET. Neurology. 2018;91(20):936–7.CrossRefPubMed

10.

Mahler C, Schumacher M, Unterrainer M, Vomacka L, Lindner S, Rupprecht R, et al. Monitoring CNS inflammatory activity in natalizumab related PML with TSPO-PET. Mult Scler J. 2018;24:37–8.

11.

Brendel M, Probst F, Jaworska A, Overhoff F, Korzhova V, Albert NL, et al. Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer PET study. J Nucl Med. 2016;57(6):954–60.CrossRefPubMed

12.

Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, et al. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [18F]GE180 PET quantification. Neuroimage. 2018;165:83–91.CrossRefPubMed

13.

Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22(2):191–204.CrossRefPubMedPubMedCentral

14.

Sridharan S, Lepelletier F-X, Trigg W, Banister S, Reekie T, Kassiou M, et al. Comparative evaluation of three TSPO PET radiotracers in a LPS-induced model of mild neuroinflammation in rats. Mol Imaging Biol. 2017;19(1):77–89.CrossRefPubMed

15.

Cumming P, Burgher B, Patkar O, Breakspear M, Vasdev N, Thomas P, et al. Sifting through the surfeit of neuroinflammation tracers. J Cereb Blood Flow Metab. 2018;38(2):204–24.CrossRefPubMed

16.

Sridharan S, Raffel J, Nandoskar A, Record C, Brooks D, Owen D, et al. Confirmation of specific binding of the 18 kDa translocator protein (TSPO) radioligand [F-18] GE-180: a blocking study using XDB173 in multiple sclerosis normal appearing white and grey matter. Mol Imaging Biol. 2019;24:421–2. https://doi.org/10.1007/s11307-019-01323-8

17.

Feeney C, Scott G, Raffel J, Roberts S, Coello C, Jolly A, et al. Kinetic analysis of the translocator protein positron emission tomography ligand [18F] GE-180 in the human brain. Eur J Nucl Med Mol Imaging. 2016;43(12):2201–10.CrossRefPubMedPubMedCentral

18.

Fan Z, Calsolaro V, Atkinson RA, Femminella GD, Waldman A, Buckley C, et al. Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein. J Nucl Med. 2016;57(11):1753–9.CrossRefPubMed

19.

Jaremko Ł, Jaremko M, Giller K, Becker S, Zweckstetter M. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science. 2014;343(6177):1363–6.CrossRefPubMedPubMedCentral

20.

Jaremko M, Jaremko Ł, Giller K, Becker S, Zweckstetter M. Structural integrity of the A147T polymorph of mammalian TSPO. Chembiochem. 2015;16(10):1483–9.CrossRefPubMedPubMedCentral

Titel: In response to: The validity of 18F-GE180 as a TSPO imaging agent
verfasst von: Nathalie L. Albert
Marcus Unterrainer
Matthias Brendel
Lena Kaiser
Markus Zweckstetter
Paul Cumming
Peter Bartenstein
Publikationsdatum: 02.03.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2019
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-019-04294-8

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2019

Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers

Low hexokinase-2 expression-associated false-negative 18F-FDG PET/CT as a potential prognostic predictor in patients with multiple myeloma

Comparison of image quality and lesion detection between digital and analog PET/CT

FDG atrial uptake is associated with an increased prevalence of stroke in patients with atrial fibrillation

Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume

The potential for PET-guided revascularization of coronary artery disease